News
Zacks Investment Research on MSN4d
Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is ...
Recursion Pharmaceuticals Inc Class A Recursion Pharmaceuticals Inc Class A RXRX Stock XNAS Rating as of Jul 25, 2025 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Key Metrics ...
The REV102 program originated from a joint venture between Rallybio and Recursion focused on the discovery and development of novel, orally available small molecule inhibitors of ENPP1 for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback